New developments in portal hypertensive bleeding

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Portal hypertensive bleeding can arise from a spectrum of conditions, including esophageal, gastric, and ectopic varices, portal gastropathy, and portal colopathy. Esophageal variceal hemorrhage causes the greatest morbidity and mortality and occurs through a combination of elevated portal pressure and local factors within the varix itself. Management of esophageal varices encompasses the primary prophylaxis of variceal hemorrhage, treatment of actively bleeding varices, and secondary prophylaxis to prevent variceal rebleeding. Therapeutic approaches for these different clinical scenarios include pharmacology therapy with octreotide or beta-adrenergic blocking agents, endoscopic therapy with variceal band ligation and sclerotherapy, and portosystemic shunts performed either surgically or by interventional radiography.

Original languageEnglish (US)
Pages (from-to)17-22
Number of pages6
JournalClinical Perspectives in Gastroenterology
Volume5
Issue number1
StatePublished - 2002

Fingerprint

Hemorrhage
Esophageal and Gastric Varices
Varicose Veins
Interventional Radiography
Surgical Portasystemic Shunt
Portal Pressure
Adrenergic beta-Antagonists
Sclerotherapy
Octreotide
Therapeutics
Ligation
Pharmacology
Morbidity
Mortality

ASJC Scopus subject areas

  • Gastroenterology

Cite this

New developments in portal hypertensive bleeding. / Shah, Vijay; Kamath, Patrick Sequeira.

In: Clinical Perspectives in Gastroenterology, Vol. 5, No. 1, 2002, p. 17-22.

Research output: Contribution to journalArticle

@article{3bffad4376654cb68a959f232d248ccd,
title = "New developments in portal hypertensive bleeding",
abstract = "Portal hypertensive bleeding can arise from a spectrum of conditions, including esophageal, gastric, and ectopic varices, portal gastropathy, and portal colopathy. Esophageal variceal hemorrhage causes the greatest morbidity and mortality and occurs through a combination of elevated portal pressure and local factors within the varix itself. Management of esophageal varices encompasses the primary prophylaxis of variceal hemorrhage, treatment of actively bleeding varices, and secondary prophylaxis to prevent variceal rebleeding. Therapeutic approaches for these different clinical scenarios include pharmacology therapy with octreotide or beta-adrenergic blocking agents, endoscopic therapy with variceal band ligation and sclerotherapy, and portosystemic shunts performed either surgically or by interventional radiography.",
author = "Vijay Shah and Kamath, {Patrick Sequeira}",
year = "2002",
language = "English (US)",
volume = "5",
pages = "17--22",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - New developments in portal hypertensive bleeding

AU - Shah, Vijay

AU - Kamath, Patrick Sequeira

PY - 2002

Y1 - 2002

N2 - Portal hypertensive bleeding can arise from a spectrum of conditions, including esophageal, gastric, and ectopic varices, portal gastropathy, and portal colopathy. Esophageal variceal hemorrhage causes the greatest morbidity and mortality and occurs through a combination of elevated portal pressure and local factors within the varix itself. Management of esophageal varices encompasses the primary prophylaxis of variceal hemorrhage, treatment of actively bleeding varices, and secondary prophylaxis to prevent variceal rebleeding. Therapeutic approaches for these different clinical scenarios include pharmacology therapy with octreotide or beta-adrenergic blocking agents, endoscopic therapy with variceal band ligation and sclerotherapy, and portosystemic shunts performed either surgically or by interventional radiography.

AB - Portal hypertensive bleeding can arise from a spectrum of conditions, including esophageal, gastric, and ectopic varices, portal gastropathy, and portal colopathy. Esophageal variceal hemorrhage causes the greatest morbidity and mortality and occurs through a combination of elevated portal pressure and local factors within the varix itself. Management of esophageal varices encompasses the primary prophylaxis of variceal hemorrhage, treatment of actively bleeding varices, and secondary prophylaxis to prevent variceal rebleeding. Therapeutic approaches for these different clinical scenarios include pharmacology therapy with octreotide or beta-adrenergic blocking agents, endoscopic therapy with variceal band ligation and sclerotherapy, and portosystemic shunts performed either surgically or by interventional radiography.

UR - http://www.scopus.com/inward/record.url?scp=0036141613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036141613&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 17

EP - 22

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 1

ER -